N.J. cancer Dx firm looks to obtain $6M from IPO

04/8/2013 | GenomeWeb Daily News (free registration)

Cancer Genetics hopes to raise $6 million in an initial public offering. The Rutherford, N.J.-based company will use part of the proceeds to finance its joint initiative with the Mayo Foundation for Medical Education and Research to use advanced sequencing technology to develop cancer diagnostic tests and services.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ